Sit Investment Associates Inc. Has $2,313,000 Position in Steris Corp. (STE)
Sit Investment Associates Inc. reduced its stake in shares of Steris Corp. (NYSE:STE) by 6.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 33,650 shares of the company’s stock after selling 2,200 shares during the period. Sit Investment Associates Inc.’s holdings in Steris Corp. were worth $2,313,000 as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of the stock. BKD Wealth Advisors LLC bought a new position in Steris Corp. during the second quarter worth $208,000. Mount Lucas Management LP bought a new position in Steris Corp. during the first quarter worth $313,000. Diversified Trust Co bought a new position in Steris Corp. during the second quarter worth $320,000. Virginia Retirement System bought a new position in Steris Corp. during the first quarter worth $341,000. Finally, Miles Capital Inc. increased its position in Steris Corp. by 28.7% in the first quarter. Miles Capital Inc. now owns 5,114 shares of the company’s stock worth $363,000 after buying an additional 1,141 shares in the last quarter. Hedge funds and other institutional investors own 91.58% of the company’s stock.
Steris Corp. (NYSE:STE) traded up 1.398% on Monday, reaching $72.266. 199,537 shares of the company traded hands. The stock has a market capitalization of $6.23 billion, a price-to-earnings ratio of 41.508 and a beta of 1.13. The stock’s 50-day moving average is $71.44 and its 200-day moving average is $70.40. Steris Corp. has a 1-year low of $61.38 and a 1-year high of $78.77.
Steris Corp. (NYSE:STE) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.02. Steris Corp. had a net margin of 5.52% and a return on equity of 10.72%. The firm earned $638.40 million during the quarter, compared to analysts’ expectations of $639.04 million. During the same period in the previous year, the company earned $0.62 earnings per share. The firm’s quarterly revenue was up 45.1% on a year-over-year basis. Equities research analysts expect that Steris Corp. will post $3.90 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 27th. Stockholders of record on Tuesday, August 30th were issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.57%. This is a boost from Steris Corp.’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend was Friday, August 26th. Steris Corp.’s payout ratio is presently 68.71%.
Separately, Zacks Investment Research downgraded shares of Steris Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, August 3rd.
In other news, insider Daniel A. Carestio sold 2,681 shares of the business’s stock in a transaction that occurred on Friday, August 12th. The shares were sold at an average price of $71.04, for a total transaction of $190,458.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Sudhir K. Pahwa sold 1,028 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $70.13, for a total transaction of $72,093.64. The disclosure for this sale can be found here. Insiders own 2.52% of the company’s stock.
Steris Corp. Company Profile
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.